切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2022, Vol. 11 ›› Issue (01) : 18 -23. doi: 10.3877/cma.j.issn.2095-3224.2022.01.003

专家论坛

国内外结直肠癌筛查的对比分析及启示
刘正1, 王锡山1,()   
  1. 1. 100021 北京,国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医院肿瘤医院结直肠外科
  • 收稿日期:2021-12-26 出版日期:2022-02-25
  • 通信作者: 王锡山
  • 基金资助:
    中国医学科学院中央级公益性科研院所基本科研业务费(2021-RC310-009)

Comparative analysis and inspiration of colorectal cancer screening at China and abroad

Zheng Liu1, Xishan Wang1,()   

  1. 1. Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2021-12-26 Published:2022-02-25
  • Corresponding author: Xishan Wang
引用本文:

刘正, 王锡山. 国内外结直肠癌筛查的对比分析及启示[J]. 中华结直肠疾病电子杂志, 2022, 11(01): 18-23.

Zheng Liu, Xishan Wang. Comparative analysis and inspiration of colorectal cancer screening at China and abroad[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2022, 11(01): 18-23.

我国结直肠癌的发病率和死亡率在逐年升高,严重威胁人民群众的健康,亟待采取行之有效并且适合我国国情的结直肠癌筛查策略,从而降低结直肠癌的疾病负担。目前面临的突出问题是,我国人群结直肠癌筛查项目覆盖尚不广泛,方法并不统一,有待形成完善的国家结直肠癌筛查体系。建立筛查体系的作用在于发现癌前病变和早期病例,从而降低发病率并提高早期病例构成比,具有很重要的卫生经济学意义。本文结合国内外最新指南共识,阐述国内外结直肠癌筛查的历程和现状,比较了结直肠癌筛查常用的方法,并对我国筛查的发展提出了展望,以期未来能够建立具有我国特色的结直肠癌筛查策略。

The incidence and death rate of colorectal cancer has shown an upward trend in China. Colorectal cancer turns to be a great threat to people's health. There is an urgent need for my country to adopt an effective and suitable colorectal cancer screening strategy to reduce the disease burden of colorectal cancer. The prominent problem currently faced is that the coverage of colorectal cancer screening programs for the population in my country is not yet extensive, and the methods are not uniform. A comprehensive national colorectal cancer screening system needs to be formed. The role of establishing a screening system is to detect precancerous lesions and early cases, thereby reducing the incidence and increasing the proportion of early cases, which is of great significance in health economics. This article briefly descirbed the development and current status of colorectal cancer screening international, comparaed several frequently used methods, introduced the latest guidelines and consensus of colorectal cancer screening, and put forward ideas and suggestions for the establishment of colorectal cancer screening system in China.

[1]
Ferlay JEM, Lam F, Colombet M, et al. Global cancer observatory: cancer today. Lyon, france: international agency for research on cancer.[EB/OL].(2020-03-02)[2021-08-27].

URL    
[2]
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020[J]. CA: A Cancer Journal for Clinicians, 2020, 70(3): 145-164.
[3]
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
[4]
National Cancer Institute. Cancer Stat Facts: Colorectal Cancer[EB/OL].(2017-02-07) [2021-08-27].

URL    
[5]
Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies[J]. Bmj, 2014, 348: g2467.
[6]
NdPilonis, Bugajski M, Wieszczy P, et al. Long-term colorectal cancer incidence and mortality after a single negative screening colonoscopy [J]. Ann Intern Med, 2020, 173(2): 81-91.
[7]
Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer[J]. N Engl J Med, 2013, 369(12): 1106-1114.
[8]
CHIU HM, CHEN SL, YEN AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program[J]. Cancer, 2015, 121(18): 3221-3229.
[9]
Lin JS, Perdue LA, Henrikson NB, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force[J]. JAMA, 2021, 325(19): 1978-1997.
[10]
王红, 黄慧瑶, 刘成成, 等. 我国结直肠癌筛查卫生经济学证据系统更新:2009-2018[J]. 中华流行病学杂志, 2020, 41(3): 429-435.
[11]
健康中国行动推进委员会. 健康中国行动(2019-2030年)[EB/OL].(2019-07-15)[2021-08-27].

URL    
[12]
Guo F, De Brabander I, Francart J, et al. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme[J]. Br J Cancer, 2020, 122(7): 1109-1117.
[13]
Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis[J]. Prev Med, 2012, 55(2): 87-92.
[14]
Tinmouth J, Lansdorp-vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know[J]. Gut, 2015, 64(8): 1327-1337.
[15]
国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组. 中国结直肠癌筛查与早诊早治指南(2020,北京)[J]. 中华肿瘤杂志, 2021, 43(1): 16-38.
[16]
Allison JE, Fraser CG, Halloran SP, et al. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT)[J]. Gut Liver, 2014, 8(2): 117-130.
[17]
Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening[J]. N Engl J Med, 2014, 370(14): 1287-1297.
[18]
关旭, 马晨曦, 王炜, 等. 多靶点粪便FIT-DNA检测技术在结直肠癌患者、配偶及一级亲属筛查中的应用研究[J/OL]. 中华结直肠疾病电子杂志, 2021, 10(3): 237-242.
[19]
Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy[J]. N Engl J Med, 2012, 366(25): 2345-2357.
[20]
U.S. Centers for Disease Control and Prevention. Colorectal Cancer Statistics[EB/OL]. (2021-07-08) [2021-08-27].

URL    
[21]
Cancer Research UK. Bowel Cancer Screening Coverage and Uptake, UK, FY2012-2015[EB/OL].(2021-07-31) [2021-08-27].

URL    
[22]
Singh H, Bernstein CN, Samadder JN, et al. Screening rates for colorectal cancer in Canada: a cross-sectional study[J]. CMAJ Open, 2015, 3(2): E149-157.
[23]
Australian Institute of Health and Welfare. Bowel cancer screening in Australia[EB/OL].(2020-07-31) [2021-08-27].

URL    
[24]
厚生労働省. 2019年国民生活基礎調査の概況[EB/OL].(2010-07-17) [2021-08-27].

URL    
[25]
Hong S, Lee YY, Lee J, et al. Trends in cancer screening rates among korean men and women: results of the Korean national cancer screening survey, 2004—2018[J]. Cancer Res Treat, 2021, 53(2): 330-338.
[26]
衛生福利部國民健康署. 102年50-69歲民眾最近兩年內接受大腸癌篩檢率[EB/OL].(2016-04-15)[2021-08-27].

URL    
[27]
高乐, 于树青, 杨继春, 等. 全球结直肠癌筛查指南的质量评价[J]. 北京大学学报(医学版), 2019, 51(3): 176-183.
[28]
田剑波, 温艳, 杨卓煜, 等. 全球结直肠癌筛查指南及共识质量评价[J]. 中华流行病学杂志, 2021, 42(2): 248-257.
[29]
Davidson KW, Barry MJ, Mangione CM, et al. Screening for colorectal cancer: US preventive services task force recommendation statement [J]. JAMA, 2021, 325(19): 1965-1977.
[30]
Shaukat A, Kahi CJ, Burke CA, et al. ACG Clinical Guidelines: Colorectal Cancer Screening 2021[J]. Am J Gastroenterol, 2021, 116(3): 458-479.
[31]
吴春晓, 顾凯, 龚杨明, 等. 2015年中国结直肠癌发病和死亡情况分析[J]. 中国癌症杂志, 2020, 30(4): 241-245.
[32]
Zheng GM, Choi BC, Yu XR, et al. Mass screening for rectal neoplasm in Jiashan County, China[J]. J Clin Epidemiol, 1991, 44(12): 1379-1385.
[33]
杨金华, 沈飞琼, 薛峰, 等. 2007-2016年浙江省嘉善县结直肠癌筛查方案应用评价[J]. 中国肿瘤, 2020, 29(12): 919-924.
[34]
陈万青, 李霓, 曹毛毛, 等. 2013-2017年中国城市癌症早诊早治项目基线结果分析[J]. 中国肿瘤, 2020, 29(1): 1-6.
[35]
陈宏达, 李霓, 任建松, 等. 中国城市结直肠癌高危人群的结肠镜筛查依从性及其相关因素分析[J]. 中华预防医学杂志, 2018, 52(3): 231-237.
[36]
安锦慧, 孙治平, 李云涛, 等. 我国结直肠癌筛查的影响因素文献分析及思考[J]. 中国全科医学, 2020, 23(23): 2877-2882.
[37]
国家消化系统疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化内镜学分会, 等. 中国早期结直肠癌筛查流程专家共识意见(2019, 上海)[J]. 中华医学杂志, 2019, 99 (38): 2961-2970.
[38]
王锡山. 中美结直肠癌流行病学特征及防诊治策略的对比分析[J/OL]. 中华结直肠疾病电子杂志, 2017, 6(6): 447-453.
[39]
张愉涵, 陈宏达, 卢明, 等. 结直肠癌筛查和早期诊断生物标志物研究进展[J]. 中华流行病学杂志, 2021, 42(1): 142-148.
[40]
Tepus M, Yau TO. Non-Invasive Colorectal Cancer Screening: An Overview[J]. Gastrointest Tumors, 2020, 7(3): 62-73.
[41]
胡茜玥, 刘正, 王锡山. 结直肠癌筛查策略的研究现状与思考[J]. 中国全科医学, 2021, 24(33): 4165-4171.
[1] 旺久, 陈军, 朱霞, 米玛央金, 赵胜, 陈欣林, 李建华, 王双. 山南市妇幼保健院开展胎儿系统超声筛查的效果分析[J]. 中华医学超声杂志(电子版), 2023, 20(07): 728-733.
[2] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[3] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[4] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[5] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[6] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[7] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[8] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
[9] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[10] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[11] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[12] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[13] 黄怡诚, 陆晨, 孙司正, 喻春钊. 肝特异性转录因子FOXA2在人结直肠癌肝转移阶梯模型中的表达变化及其意义[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 396-403.
[14] 刘祺, 张凯, 李建男, 刘铜军. 结直肠癌肝转移生物治疗的现状及进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 415-419.
[15] 孙昕, 程海波, 沈卫星. 基于全转录组学探讨仙连解毒方治疗Ⅲ期结直肠癌患者的疗效机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 277-283.
阅读次数
全文


摘要